GermFlare Announces Its Professional Handheld UVC Light Kills 99.99% of MRSA and P. Aeruginosa in Laboratory Testing

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

March 2, 2021

GermFlare, based in Denmark, today proudly reported its handheld UVC light called “GermFlare” to achieve greater than 99.99%, or 4log, inactivation of both Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa (PA) in less than 5 seconds at a distance of 3.9 inches (10 cm).

Testing on the two bacteria strains was conducted by ALS Denmark A/S (part of ALS Laboratories), an accredited global certified laboratory.

GermFlare, UVC

The testing parameters were carefully selected to simulated how the effect of the GermFlare would be in the hands of its core user, the healthcare personnel at hospitals. GermFlare has previously been proven to inactivate SARS-CoV-2 at the Department of Immunology and Microbiology and Department of Infectious Diseases, Hvidovre Hospital, Denmark.

“Our focus is to provide a solution to the global Hospital Acquired Infection (HAI) problem and as MRSA is one of those bacteria our core users fight against every day, we are very pleased with the results.”

“We hope this test and the results can provide some comfort and confidence to the Healthcare personnel working in areas where there is an increased risk of contracting HAIs.”

“When the user starts to incorporate the use of GermFlare more in their daily routines the risk of being infected by any harmful pathogen decreases noticeable, and it could just be a quick 5-second treatment of any hotspots they touch. Even if the nurse forgets to use rubbing alcohol after they touched a door handle, they do not need to worry because if they used the GermFlare it would have killed the harmful pathogens and broken the chain of infection.” – states Flemming Dahlin, Chief Executive Officer, GermFlare.

 

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.